RxSight (NASDAQ:RXST) Price Target Cut to $35.00 by Analysts at Wells Fargo & Company

RxSight (NASDAQ:RXST – Free Report) had its target price trimmed by Wells Fargo & Company from $40.00 to $35.00 in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts also recently commented on the company. UBS Group assumed coverage on […]

Mar 1, 2025 - 10:09

RxSight (NASDAQ:RXST – Free Report) had its target price trimmed by Wells Fargo & Company from $40.00 to $35.00 in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts also recently commented on the company. UBS Group assumed coverage on […]